Literature DB >> 20515733

Focal adhesion kinase and p53 signal transduction pathways in cancer.

Vita M Golubovskaya1, William Cance.   

Abstract

Human cancer is characterized by a process of tumor cell motility, invasion, and metastasis. One of the critical tyrosine kinases that is linked to these processes of tumor invasion and survival is the Focal Adhesion Kinase (FAK). Our laboratory was the first to isolate FAK from human tumors, and we had demonstrated that FAK mRNA was up-regulated in invasive and metastatic human breast and colon cancer samples. We have cloned FAK promoter and have found that FAK promoter contains p53 binding sites, and that p53 inhibits FAK transcription and regulates its expression in tumor samples. In addition, we have found a high correlation between FAK overexpression and p53 mutations in 600 population-based series of breast cancer patients. found that N-myc binds FAK promoter and induces FAK transcription in neuroblastoma cells. Thus, this review will be focused on FAK and p53 signal transduction pathways in cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515733      PMCID: PMC3136041          DOI: 10.2741/3653

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  114 in total

1.  Focal adhesion kinase is activated in invading fibrosarcoma cells and regulates metastasis.

Authors:  Masuo Hanada; Kazuhiro Tanaka; Yoshihiro Matsumoto; Fumihiko Nakatani; Riku Sakimura; Tomoya Matsunobu; Xu Li; Takamitsu Okada; Tomoyuki Nakamura; Minoru Takasaki; Yukihide Iwamoto
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 2.  The complexity of p53 modulation: emerging patterns from divergent signals.

Authors:  A J Giaccia; M B Kastan
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

3.  Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells.

Authors:  L H Xu; L V Owens; G C Sturge; X Yang; E T Liu; R J Craven; W G Cance
Journal:  Cell Growth Differ       Date:  1996-04

4.  PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway.

Authors:  M Tamura; J Gu; E H Danen; T Takino; S Miyamoto; K M Yamada
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

5.  A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.

Authors:  Vita M Golubovskaya; Carl Nyberg; Min Zheng; Frederick Kweh; Andrew Magis; David Ostrov; William G Cance
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

6.  Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases.

Authors:  Cedo M Bagi; Gregory W Roberts; Catharine J Andresen
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

7.  Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src.

Authors:  M D Schaller; J D Hildebrand; J D Shannon; J W Fox; R R Vines; J T Parsons
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

8.  Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.

Authors:  Walter Gregory Roberts; Ethan Ung; Pamela Whalen; Beth Cooper; Catherine Hulford; Christofer Autry; Daniel Richter; Earling Emerson; Jing Lin; John Kath; Kevin Coleman; Lili Yao; Luis Martinez-Alsina; Marianne Lorenzen; Martin Berliner; Michael Luzzio; Nandini Patel; Erika Schmitt; Susan LaGreca; Jitesh Jani; Matt Wessel; Eric Marr; Matt Griffor; Felix Vajdos
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

9.  Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis.

Authors:  Lucia Beviglia; Vita Golubovskaya; LiHui Xu; XiHui Yang; Rolf J Craven; William G Cance
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

10.  Regulation of focal adhesion kinase by its amino-terminal domain through an autoinhibitory interaction.

Authors:  Lee Ann Cooper; Tang-Long Shen; Jun-Lin Guan
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more
  34 in total

Review 1.  High-throughput screening strategies for targeted identification of therapeutic compounds in colorectal cancer.

Authors:  Agnieszka B Bialkowska; Vincent W Yang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

2.  Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated.

Authors:  Baotran Ho; Gretchen Olson; Sheila Figel; Irwin Gelman; William G Cance; Vita M Golubovskaya
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

Review 3.  Focal adhesion complex proteins in epidermis and squamous cell carcinoma.

Authors:  Elizabeth K Duperret; Todd W Ridky
Journal:  Cell Cycle       Date:  2013-09-12       Impact factor: 4.534

Review 4.  Targeting the p53 pathway.

Authors:  Vita M Golubovskaya; William G Cance
Journal:  Surg Oncol Clin N Am       Date:  2013-07-30       Impact factor: 3.495

5.  Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.

Authors:  Damián E Berardi; Carolina Flumian; Paola B Campodónico; Alejandro J Urtreger; María I Diaz Bessone; Andrea N Motter; Elisa D Bal de Kier Joffé; Eduardo F Farias; Laura B Todaro
Journal:  Cell Oncol (Dordr)       Date:  2015-06-05       Impact factor: 6.730

6.  The microarray gene profiling analysis of glioblastoma cancer cells reveals genes affected by FAK inhibitor Y15 and combination of Y15 and temozolomide.

Authors:  Grace Huang; Baotran Ho; Jeffrey Conroy; Song Liu; Hu Qiang; Vita Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

7.  Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cells.

Authors:  Colleen S Curran; Esteban R Carrillo; Suzanne M Ponik; Patricia J Keely
Journal:  Environ Toxicol Pharmacol       Date:  2014-11-01       Impact factor: 4.860

8.  Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.

Authors:  Vita M Golubovskaya; Grace Huang; Baotran Ho; Michael Yemma; Carl D Morrison; Jisook Lee; Brian P Eliceiri; William G Cance
Journal:  Mol Cancer Ther       Date:  2012-12-12       Impact factor: 6.261

Review 9.  Contribution of p53 to metastasis.

Authors:  Emily Powell; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Cancer Discov       Date:  2014-03-21       Impact factor: 39.397

10.  The Misregulation of Cell Adhesion Components during Tumorigenesis: Overview and Commentary.

Authors:  Claudia D Andl
Journal:  J Oncol       Date:  2010-09-30       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.